UGA Researchers Break Ground on Flu Vaccine

Researchers at the University of Georgia and Sanofi Pasteur, a multinational pharmaceutical company announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.

Using a technique called Computationally Optimized Broadly Reactive Antigen, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.

Sanofi Pasteur and UGA researchers are set to present their data tomorrow, March 30, at the World Vaccine Congress located in Washington, D.C.

Tags:

You May Also Like

Check Out UGA’s Microscopy Lab

ATHENS - Take a look inside UGA's Microscopy lab facility.

UGA Tailgating Tactics to Plan Ahead

Every fall, tens of thousands of rowdy fans pack into Athens to cheer for ...

UGA Students Face Flight Cancellation Variances Out of LaGuardia

Flight cancellations are a nightmare for everyone, but it was especially an unfortunate ordeal ...

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close